isoxsuprine has been researched along with Gait Disorders, Animal in 3 studies
Isoxsuprine: A beta-adrenergic agonist that causes direct relaxation of uterine and vascular smooth muscle. Its vasodilating actions are greater on the arteries supplying skeletal muscle than on those supplying skin. It is used in the treatment of peripheral vascular disease and in premature labor.
Excerpt | Relevance | Reference |
---|---|---|
"Isoxsuprine has an apparent affinity for melanin that may contribute to extended renal excretion." | 2.41 | Isoxsuprine hydrochloride in the horse: a review. ( Erkert, RS; Macallister, CG, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rose, RJ | 1 |
Allen, JR | 1 |
Hodgson, DR | 1 |
Kohnke, JR | 1 |
Erkert, RS | 1 |
Macallister, CG | 1 |
Turner, AS | 1 |
Tucker, CM | 1 |
1 review available for isoxsuprine and Gait Disorders, Animal
Article | Year |
---|---|
Isoxsuprine hydrochloride in the horse: a review.
Topics: Administration, Oral; Animals; Biological Availability; Foot Diseases; Horse Diseases; Horses; Infus | 2002 |
2 trials available for isoxsuprine and Gait Disorders, Animal
Article | Year |
---|---|
Studies on isoxsuprine hydrochloride for the treatment of navicular disease.
Topics: Administration, Oral; Animals; Body Temperature; Clinical Trials as Topic; Double-Blind Method; Fema | 1983 |
The evaluation of isoxsuprine hydrochloride for the treatment of navicular disease: a double blind study.
Topics: Administration, Oral; Animals; Bursitis; Clinical Trials as Topic; Dose-Response Relationship, Drug; | 1989 |